First Merchants Corporation
NASDAQ:FRMEBanks - Regional
+$0.32 today
- Market cap
- $2.48B
- Beta
- 0.86
- P/E (TTM)
- 12.6
- EPS (TTM)
- $3.26
- Dividend yield
- 3.54%
Volume 0.37M
Average 0.35M
FRME Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
First Merchants CorporationNASDAQ: FRME
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FRME compares with its peers on the latest reported figures
- FRME's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for FRME, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding FRME) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for FRME. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 555.96M | 712.95M | 999.49M | 1.05B | 1.05B |
| Cost of Revenue | 35.95M | 101.56M | 351.99M | 462.59M | 410.03M |
| Gross Profit | 520M | 611.39M | 647.5M | 591.01M | 640.17M |
| Gross Margin | 93.5% | 85.8% | 64.8% | 56.1% | 61.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 179M | 224.84M | 250.85M | 243.59M | 282.1M |
| Operating Expenses | 279.21M | 355.72M | 388.27M | 359.28M | 381.06M |
| Depreciation & Amortization | 10.7M | 11.82M | 11.71M | 26.85M | 29.42M |
| EBITDA | 251.49M | 267.49M | 270.94M | 258.58M | 288.54M |
| EBITDA Margin | 45.2% | 37.5% | 27.1% | 24.5% | 27.5% |
| Operating Income | 240.79M | 255.67M | 259.23M | 231.73M | 259.11M |
| Operating Margin | 43.3% | 35.9% | 25.9% | 22.0% | 24.7% |
| Interest Income | 446.63M | 605.01M | 893.89M | 948.01M | 924.79M |
| Interest Expense | 35.95M | 84.8M | 348.49M | 426.89M | 388.78M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 240.79M | 255.67M | 259.23M | 231.73M | 259.11M |
| Pre-Tax Margin | 43.3% | 35.9% | 25.9% | 22.0% | 24.7% |
| Income Tax Expense | 35.26M | 33.59M | 35.45M | 30.33M | 33.11M |
| Net Income | 205.53M | 222.09M | 223.79M | 201.4M | 226M |
| Net Margin | 37.0% | 31.2% | 22.4% | 19.1% | 21.5% |
| EPS (Basic) | 3.82 | 3.83 | 3.74 | 3.42 | 3.90 |
| EPS (Diluted) | 3.81 | 3.81 | 3.73 | 3.41 | 3.88 |
| Weighted Avg Shares | 53.78M | 57.69M | 59.31M | 58.31M | 57.73M |
| Weighted Avg Shares (Diluted) | 53.98M | 57.95M | 59.49M | 58.53M | 57.73M |
First Merchants Corporation
NASDAQ:FRME
Intrinsic Alpha fair value
Locked
Current Price
$39.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.